1. Home
  2. 5AM Ventures

Category: Pharma and Healthcare

5AM Ventures ups fundraising ante with $750m across new flagship, later-stage funds

Biopharma, medical tech and life sciences-focused 5AM Ventures has raised $750m across a new pair of funds targeting startups across the early and late-stage of investment. The post 5AM Ventures ups fundraising ante with $750m

Specialist healthcare funds on track for another record year

European healthcare specialist funds are on track for another record-breaking year with more than EUR 4.4bn raised in the first fourth months of 2022, Unquote Data shows.

Brightline Fuels National Expansion of Virtual, Equitable, and Affordable Family Behavioral Health Care with a $105M Series C Raise, Led by KKR

Brightline, the category leader in virtual behavioral health care for children, adolescents, and families, today announced it has secured a $105M Series C funding, bringing the company's total funding to over $200M. Global investment firm

Thomas H Lee Partners agrees to by Warburg Pincus-backed Intelligent Medical Objects

US private equity major Thomas H Lee Partners has agreed to buy a majority stake in Warburg Pincus' healthcare data and documentation software specialist Intelligent Medical Objects. The post Thomas H Lee Partners agrees to

Summit buys 18 Week Support

Private equity firm Summit Partners has bought UK healthcare provider 18 Week Support, filings with Companies House show.

CVC sells Theramex to Carlyle, PAI for GBP 1.2bn

CVC Capital is to sell women’s health-focused pharmaceutical company Theramex to PAI and Carlyle; the SBO is valued at GBP 1.2bn, according to two sources familiar with the situation.

Livingbridge buys Nourish Care Systems

Mid-market sponsor Livingbridge has acquired UK-based digital medical care planning software provider Nourish Care Systems.

Mirabaud appoints Nouri as partner, plans new Lifestyle fund

Mirabaud Asset Management has appointed luxury and consumer industry expert Chabi Nouri as private equity partner; she will co-manage the GP's Lifestyle strategy, which expects to launch a second vintage later in 2022.

Audax to sell Lifemark to Loblaw Companies, marks second exit in a week

Audax Private Equity has agreed to sell Lifemark Health Group to Loblaw Companies, marking the second exit in a week. The post Audax to sell Lifemark to Loblaw Companies, marks second exit in a week

KKR-backed Biosynth Carbosynth Acquires vivitide and Welcomes Ampersand Capital Partners as New Shareholder

Combination of Biosynth Carbosynth and vivitide creates global life sciences platform serving high-growth biopharma and diagnostics end markets LONDON--(BUSINESS WIRE)-- KKR, a leading global investment firm, announced today the closing of its previously announced investment

Frazier Healthcare Partners soars past last life sciences fund total with new $987m fund close

Frazier Healthcare Partners has beaten its goal for its latest life sciences-focused fundraise by picking up $987m for a final close of the vehicle. The post Frazier Healthcare Partners soars past last life sciences fund

Hg gears up for MEDIFOX DAN exit

MEDIFOX DAN, a German healthcare software company, is being prepped for exit by sponsor Hg, four sources familiar with the situation said.

Kieran P. Murphy, Former CEO of GE Healthcare, Joins Gamma Biosciences as Executive Chairman

MENLO PARK, Calif.--(BUSINESS WIRE)-- Gamma Biosciences, a global life sciences company formed by KKR to serve the advanced therapy market with best-in-class bioprocessing solutions, today announced that Kieran P. Murphy will join its Board of

Boots sale stumbles against limited financing availability

The sale of UK-based pharmacy chain Boots may struggle to get over the finish line as bidders face limited financing options to back the prospective buyout, according to six sources familiar with the matter.

Gilde Healthcare closes €517m fund to target lower mid-market healthcare companies in Northwest Europe

Specialist healthcare investor Gilde Healthcare has held a final close for its oversubscribed fourth healthcare private equity fund on €517m. The post Gilde Healthcare closes €517m fund to target lower mid-market healthcare companies in Northwest

Jeito, INKEF, Forbion lead EUR 80m Series B for Precirix

Jeito Capital, INKEF Capital and Forbion have co-led a EUR 80m Series B for Precirix, a Belgian biotech developing precision radiopharmaceuticals.

Gilde Healthcare closes fourth buyout fund at EUR 517m

Healthcare specialist Gilde Healthcare has raised EUR 517m for its fourth buyout fund to push a buy-and-build strategy in the lower-mid market in Northwest Europe, Managing Partner Jaspar van Gorp told Unquote.

Cinven buys Bayer's Environmental Science Professional for EUR 2.4bn

Cinven has bought the environmental science arm of pharma company Bayer for USD 2.6bn (EUR 2.4bn), the latest in a slew of industrial carve-outs by the London-based private equity firm

Blackstone Growth leads financing round in biomedical data analysis software DNAnexus

Blackstone Growth has led a $200m financing round in cloud-based biomedical data analysis software DNAnexus. The post Blackstone Growth leads financing round in biomedical data analysis software DNAnexus first appeared on AltAssets Private Equity News.

CVC collects first round bids for Theramex

The sale of UK-based women’s health pharma company Theramex is underway with first-round bids due early this week, four sources familiar with the matter said.

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.